• Explore /
  • Poster
  • / Ph IB study of LEE011 and BYL719 in combination with letrozole in ER+, HER2- breast cancer.

Ph IB study of LEE011 and BYL719 in combination with letrozole in ER+, HER2- breast cancer.

Abstract Poster

Authors

null

Pamela N. Munster

University of California, San Francisco, San Francisco, CA

Pamela N. Munster , Erika Paige Hamilton , Laura G. Estevez , Richard H. De Boer , Ingrid A. Mayer , Mario Campone , Shizuka Asano , Suraj Bhansali , Vickie Zhang , Becker Hewes , Dejan Juric

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Risk Assessment, Prevention, Early Detection,  Screening, and Systemic Therapy

Track

Systemic Therapy,Risk Assessment, Prevention, Early Detection, and Screening

Sub Track

Advanced Disease

Clinical Trial Registration Number

NCT01872260

Citation

J Clin Oncol 32, 2014 (suppl 26; abstr 143)

DOI

10.1200/jco.2014.32.26_suppl.143

Abstract #

143

Poster Bd #

D15

Abstract Disclosures

Similar Posters

First Author: Pamela N. Munster

First Author: Javier Pascual

First Author: Gabriel N. Hortobagyi

First Author: Wolfgang Janni